Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pain
ADR ID BADD_A03251
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.08      Pain and discomfort NEC
08.01.08.004      Pain
Description A disorder characterized by the sensation of marked discomfort, distress or agony. [CTCAE] An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. [MeSH]
MedDRA Code 10033371
MeSH ID D010146; D059350; D010148; D059787; D053591
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Ache | Ache NOS | Burn lesion pain transient aggravation of | Exacerbation of pain | Generalised aching | Pain | Pain aggravated | Pain burning | Pain dull | Pain exacerbated | Pain irritated | Pain NOS | Pain worsened | Pain-left side | Prick pain | Prick pain feeling | Smart | Smarting | Stinging | General body pain | Chronic pain | Shooting pain | Pain localised | Irradiating pain | Lancinating pain | Throbbing pain | Intractable pain | Pain at rest | Generalized aching | Acute pain | Hemialgia | Pain upon movement | Pain localized | Referred pain | Residual pain | Kinesalgia | Radiating pain | Pain post chemotherapy | Pantalgia | Diffuse pain | Mechanical pain | Pain crisis | Pain, Burning | Burning Pain | Burning Pains | Pains, Burning | Suffering, Physical | Physical Suffering | Physical Sufferings | Sufferings, Physical | Pain, Migratory | Migratory Pain | Migratory Pains | Pains, Migratory | Pain, Radiating | Pains, Radiating | Radiating Pain | Radiating Pains | Pain, Splitting | Pains, Splitting | Splitting Pain | Splitting Pains | Aches | Pain, Crushing | Crushing Pain | Crushing Pains | Pains, Crushing
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02215Ticlopidine--
BADD_D02216Ticlopidine hydrochloride--
BADD_D02217Tigecycline--
BADD_D02218Tiludronate disodium--
BADD_D02219Timolol--
BADD_D02222Tinzaparin sodium--
BADD_D02227Tipranavir disodium--
BADD_D02229Tirofiban hydrochloride--
BADD_D02232Tobramycin--
BADD_D02236Tofacitinib1.127587%
BADD_D02241Tolcapone--
BADD_D02244Tolterodine--
BADD_D02246Tolvaptan--
BADD_D02247Topiramate--
BADD_D02248Topotecan--
BADD_D02249Topotecan hydrochloride--
BADD_D02250Toremifene citrate0.000334%
BADD_D02251Torsemide0.000728%
BADD_D02252Tositumomab--
BADD_D02254Tramadol--
BADD_D02261Tranexamic acid--
BADD_D02264Trastuzumab--
BADD_D02265Travoprost--
BADD_D02266Trazodone--
BADD_D02268Treprostinil--
BADD_D02270Tretinoin--
BADD_D02271Triamcinolone--
BADD_D02272Triamcinolone acetonide0.002319%
BADD_D02277Triazolam--
BADD_D02283Trifluridine--
The 34th Page    First    Pre   34 35 36 37 38    Next   Last    Total 38 Pages
ADReCS-Target
ADR Term Drug Name Target